Cerebellar contribution to cognitive deficits and prefrontal cortex dysfunction in Spinocerebellar Ataxia Type 1 (SCA1)

Kaelin Sbrocco,Ella Borgenheimer,Ying Zhang,Mike Koob,Marija Cvetanovic

DOI: https://doi.org/10.1101/2024.07.10.602931

2024-07-10

Abstract:The cerebellum role in cognition and its functional bi-directional connectivity with prefrontal cortex (PFC) is well recognized. However, how chronic cerebellar dysfunction affects PFC function and cognition remains less understood. Spinocerebellar ataxia type 1 (SCA1), is an inherited, fatal neurodegenerative disease caused by an abnormal expansion of glutamine (Q) encoding CAG repeats in the gene Ataxin-1 (ATXN1) and characterized by severe loss of Purkinje cells (PCs) in the cerebellum. Patients with SCA1 suffer from movement and balance deficits, cognitive decline and premature lethality. Cognitive deficits significantly impact patients quality of life, yet how exactly cerebellar degeneration contributes to cognitive deficits and PFC dysfunction in SCA1 is unknown. We have previously demonstrated that expression of mutant ATXN1 only in cerebellar Purkinje cells (PCs) is sufficient to cause cognitive deficits in a transgenic ATXN1[82Q] mouse line. To understand how cerebellar dysfunction impacts the PFC, we examined neuronal activity, synaptic density, and gene expression changes in the PFC of ATXN1[82Q] mice. Remarkably, we found decreased neuronal activity, reduced synaptic density, and altered expression of immediate early genes and pathways involved in glucose metabolism, inflammation and amphetamine in the PFC of ATXN1[82Q] mice. Furthermore, we characterized cellular and molecular PFC dysfunction in a novel conditional knock-in SCA1 line, f-ATXN1146Q mice, expressing floxed human expanded ATXN1 throughout the brain. Intriguingly, we found an increased number of neurons, increased synaptic density and large gene expression alterations in the PFC of f-ATXN1146Q mice. Finally, to precisely determine the role of cerebellar dysfunction in cognitive deficits and PFC dysfunction in SCA1, we crossed f-ATXN1146Q mice with Pcp2-Cre mice expressing Cre recombinase in PCs to delete expanded ATXN1 only in PCs. Surprisingly, we have found that deleting expanded ATXN1 in PCs exacerbated cognitive deficits and PFC dysfunction in these mice. Our findings demonstrate that circumscribed cerebellar dysfunction is sufficient to impact PFC activity and synaptic connectivity impairing cognition. However, when multiple brain regions are impacted in disease, cerebellar dysfunction may ameliorate PFC pathology and cognitive performance.

Neuroscience

What problem does this paper attempt to address?

The paper aims to explore how cerebellar dysfunction affects the function of the prefrontal cortex (PFC) and cognitive deficits, particularly in Spinocerebellar Ataxia Type 1 (SCA1). Specifically, the paper attempts to answer the following questions:

1. **Impact of cerebellar dysfunction on PFC**: The study investigates how cerebellar dysfunction in SCA1 leads to reduced neural activity, decreased synaptic density, and changes in gene expression in the PFC.

2. **Role of mutant ATXN1 protein in cerebellar Purkinje cells**: Using a transgenic mouse model (ATXN1[82Q]), the research found that expressing the mutant ATXN1 protein solely in cerebellar Purkinje cells is sufficient to cause cognitive deficits.

3. **Study of conditional knock-in mouse model**: Utilizing a conditional knock-in mouse model (f-ATXN1146Q), the study examined the cellular and molecular pathological changes in the PFC when the mutant ATXN1 protein is expressed throughout the brain.

4. **Effect of deleting mutant ATXN1 in cerebellar Purkinje cells**: By crossing f-ATXN1146Q mice with Pcp2-Cre mice to specifically delete the mutant ATXN1 in cerebellar Purkinje cells, the research found that this manipulation actually exacerbated cognitive deficits and PFC dysfunction.

In summary, the paper seeks to reveal how cerebellar dysfunction leads to cognitive deficits in SCA1 patients by affecting the PFC and to explore the underlying molecular mechanisms.